Stapgen

Stapgen

Early Stage

We aim to prevent T2DM prior to the rise of blood sugar.

We aim to prevent T2DM prior to the rise of blood sugar.

Overview

Raised this Round: Raised: $0

Total Commitments ($USD)

Platform

Wefunder

Start Date

11/14/2022

Close Date

12/17/2022

Min. Goal
$50,000
Max. Goal
$85,000
Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$20,000,000

Discount

0%

Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Reading, Massachusetts

Business Type

Growth

Stapgen, with a valuation of $20 million, is raising funds on Wefunder. The company has developed its patented STAP-Test, used as the preventive test for Type 2 diabetes. The test will be used to detect the risk of Type 2 diabetes in advance, even before the rise of blood sugar, so that the disease can be intercepted. Stapgen is led by an experienced team and has granted a patent for the US with patents pending in other countries. Biplab K. Malo founded Stapgen in February 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $85,000. The campaign proceeds will be used for product development, lab rental, and product promotion.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 11/14/2022
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Stapgen on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $20,000,000

Follow company

Follow Stapgen on Wefunder 2022

Buy Stapgen's Deal Report

Warning: according to the close date for this deal, Stapgen may no longer be accepting investments.

Stapgen Deal Report

Get KingsCrowd’s comprehensive report on Stapgen including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Stapgen is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Stapgen deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge